nodes	percent_of_prediction	percent_of_DWPC	metapath
Conivaptan—CYP3A4—chronic kidney failure	0.715	1	CbGaD
Conivaptan—AVPR2—nephron—chronic kidney failure	0.0364	0.371	CbGeAlD
Conivaptan—AVPR2—urine—chronic kidney failure	0.0292	0.297	CbGeAlD
Conivaptan—AVPR2—nephron tubule—chronic kidney failure	0.00785	0.0801	CbGeAlD
Conivaptan—AVPR2—renal system—chronic kidney failure	0.00714	0.0728	CbGeAlD
Conivaptan—AVPR2—kidney—chronic kidney failure	0.0069	0.0704	CbGeAlD
Conivaptan—CYP3A4—urine—chronic kidney failure	0.00444	0.0453	CbGeAlD
Conivaptan—Atorvastatin—HMGCR—chronic kidney failure	0.0026	0.205	CrCbGaD
Conivaptan—CYP3A4—blood plasma—chronic kidney failure	0.00232	0.0236	CbGeAlD
Conivaptan—Deferasirox—CYP3A4—chronic kidney failure	0.00154	0.121	CrCbGaD
Conivaptan—Atorvastatin—CYP2B6—chronic kidney failure	0.00138	0.108	CrCbGaD
Conivaptan—Lomitapide—CYP3A4—chronic kidney failure	0.00121	0.0955	CrCbGaD
Conivaptan—Atorvastatin—ABCC2—chronic kidney failure	0.0012	0.094	CrCbGaD
Conivaptan—CYP3A4—renal system—chronic kidney failure	0.00109	0.0111	CbGeAlD
Conivaptan—Tolvaptan—CYP3A4—chronic kidney failure	0.00108	0.0851	CrCbGaD
Conivaptan—CYP3A4—kidney—chronic kidney failure	0.00105	0.0107	CbGeAlD
Conivaptan—Lomitapide—ABCB1—chronic kidney failure	0.00101	0.0795	CrCbGaD
Conivaptan—Tolvaptan—ABCB1—chronic kidney failure	0.000901	0.0708	CrCbGaD
Conivaptan—CYP3A4—digestive system—chronic kidney failure	0.000891	0.00909	CbGeAlD
Conivaptan—CYP3A4—blood—chronic kidney failure	0.000849	0.00866	CbGeAlD
Conivaptan—Atorvastatin—CYP2C19—chronic kidney failure	0.000831	0.0654	CrCbGaD
Conivaptan—Atorvastatin—CYP3A4—chronic kidney failure	0.000529	0.0416	CrCbGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—AVP—chronic kidney failure	0.000449	0.00258	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—AVP—chronic kidney failure	0.000446	0.00256	CbGpPWpGaD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—CCR5—chronic kidney failure	0.000446	0.00256	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—POMC—chronic kidney failure	0.000445	0.00255	CbGpPWpGaD
Conivaptan—CYP3A4—Tryptophan metabolism—CYP2C18—chronic kidney failure	0.000443	0.00254	CbGpPWpGaD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—CCR5—chronic kidney failure	0.000443	0.00254	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—F2—chronic kidney failure	0.000442	0.00254	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—POMC—chronic kidney failure	0.000442	0.00253	CbGpPWpGaD
Conivaptan—Atorvastatin—ABCB1—chronic kidney failure	0.00044	0.0346	CrCbGaD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—CCL2—chronic kidney failure	0.000435	0.0025	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—CCL2—chronic kidney failure	0.000432	0.00248	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic kidney failure	0.000427	0.00245	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic kidney failure	0.000424	0.00243	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL5—chronic kidney failure	0.000424	0.00243	CbGpPWpGaD
Conivaptan—CYP3A4—Xenobiotics—CYP1A1—chronic kidney failure	0.000421	0.00241	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL5—chronic kidney failure	0.000421	0.00241	CbGpPWpGaD
Conivaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2B6—chronic kidney failure	0.000413	0.00237	CbGpPWpGaD
Conivaptan—CYP3A4—Oxidation by Cytochrome P450—CYP2B6—chronic kidney failure	0.000408	0.00234	CbGpPWpGaD
Conivaptan—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic kidney failure	0.000405	0.00232	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCR5—chronic kidney failure	0.000382	0.00219	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCR5—chronic kidney failure	0.000379	0.00217	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—CRHR1—chronic kidney failure	0.000368	0.00211	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CRHR1—chronic kidney failure	0.000365	0.00209	CbGpPWpGaD
Conivaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—chronic kidney failure	0.000363	0.00208	CbGpPWpGaD
Conivaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—chronic kidney failure	0.000358	0.00205	CbGpPWpGaD
Conivaptan—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—chronic kidney failure	0.000353	0.00203	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—AVP—chronic kidney failure	0.000342	0.00196	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—AVP—chronic kidney failure	0.00034	0.00195	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—PTH—chronic kidney failure	0.000337	0.00193	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—chronic kidney failure	0.000335	0.00192	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CRHR1—chronic kidney failure	0.000334	0.00192	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—PTH—chronic kidney failure	0.000334	0.00192	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CRHR1—chronic kidney failure	0.000332	0.0019	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—F2—chronic kidney failure	0.000328	0.00188	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—EDN1—chronic kidney failure	0.000325	0.00187	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—F2—chronic kidney failure	0.000325	0.00187	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—EDN1—chronic kidney failure	0.000323	0.00185	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—CCL5—chronic kidney failure	0.000323	0.00185	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—CCL5—chronic kidney failure	0.00032	0.00184	CbGpPWpGaD
Conivaptan—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—chronic kidney failure	0.000314	0.0018	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PTH—chronic kidney failure	0.000306	0.00175	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PTH—chronic kidney failure	0.000303	0.00174	CbGpPWpGaD
Conivaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—chronic kidney failure	0.000299	0.00172	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—POMC—chronic kidney failure	0.000298	0.00171	CbGpPWpGaD
Conivaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—chronic kidney failure	0.000297	0.0017	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—POMC—chronic kidney failure	0.000296	0.0017	CbGpPWpGaD
Conivaptan—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—chronic kidney failure	0.000293	0.00168	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—NPY—chronic kidney failure	0.000292	0.00168	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL2—chronic kidney failure	0.000292	0.00167	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—CCR5—chronic kidney failure	0.000291	0.00167	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—chronic kidney failure	0.00029	0.00166	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—NPY—chronic kidney failure	0.00029	0.00166	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL2—chronic kidney failure	0.00029	0.00166	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—CCR5—chronic kidney failure	0.000289	0.00166	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—OXT—chronic kidney failure	0.000282	0.00162	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—CRH—chronic kidney failure	0.000282	0.00162	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—COL4A5—chronic kidney failure	0.00028	0.00161	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CRH—chronic kidney failure	0.00028	0.00161	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—OXT—chronic kidney failure	0.00028	0.00161	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—COL4A5—chronic kidney failure	0.000278	0.00159	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—NPS—chronic kidney failure	0.000267	0.00153	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—NPY—chronic kidney failure	0.000265	0.00152	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—NPS—chronic kidney failure	0.000265	0.00152	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—NPY—chronic kidney failure	0.000264	0.00151	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—AVP—chronic kidney failure	0.000263	0.00151	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—DRD1—chronic kidney failure	0.000262	0.0015	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TFDP2—chronic kidney failure	0.00026	0.00149	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—DRD1—chronic kidney failure	0.00026	0.00149	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TFDP2—chronic kidney failure	0.000259	0.00148	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—OXT—chronic kidney failure	0.000256	0.00147	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CRH—chronic kidney failure	0.000256	0.00147	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PIP5K1B—chronic kidney failure	0.000255	0.00146	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—ABCB1—chronic kidney failure	0.000255	0.00146	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—OXT—chronic kidney failure	0.000254	0.00146	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CRH—chronic kidney failure	0.000254	0.00146	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PIP5K1B—chronic kidney failure	0.000253	0.00145	CbGpPWpGaD
Conivaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—chronic kidney failure	0.000252	0.00144	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—F2—chronic kidney failure	0.00025	0.00143	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—F2—chronic kidney failure	0.000248	0.00142	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—NPS—chronic kidney failure	0.000243	0.00139	CbGpPWpGaD
Conivaptan—CYP3A4—Tryptophan metabolism—CAT—chronic kidney failure	0.000242	0.00139	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—NPS—chronic kidney failure	0.000241	0.00138	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—chronic kidney failure	0.000241	0.00138	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—DRD1—chronic kidney failure	0.000238	0.00137	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—DRD1—chronic kidney failure	0.000236	0.00136	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PGF—chronic kidney failure	0.000232	0.00133	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PGF—chronic kidney failure	0.00023	0.00132	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—POMC—chronic kidney failure	0.000227	0.0013	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—POMC—chronic kidney failure	0.000226	0.00129	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—CCL2—chronic kidney failure	0.000222	0.00128	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—CCL2—chronic kidney failure	0.000221	0.00127	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—chronic kidney failure	0.00022	0.00126	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PRKAG2—chronic kidney failure	0.000218	0.00125	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PRKAG2—chronic kidney failure	0.000217	0.00124	CbGpPWpGaD
Conivaptan—CYP3A4—Tryptophan metabolism—CYP1A1—chronic kidney failure	0.000216	0.00124	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—chronic kidney failure	0.000215	0.00123	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—PPARA—chronic kidney failure	0.000214	0.00123	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—COL4A3—chronic kidney failure	0.000207	0.00119	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—COL4A3—chronic kidney failure	0.000205	0.00118	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—HBEGF—chronic kidney failure	0.000202	0.00116	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—HBEGF—chronic kidney failure	0.000201	0.00115	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CRHR1—chronic kidney failure	0.000197	0.00113	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CRHR1—chronic kidney failure	0.000196	0.00112	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—AVP—chronic kidney failure	0.000193	0.00111	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—AVP—chronic kidney failure	0.000192	0.0011	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—LRP2—chronic kidney failure	0.000189	0.00109	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—LRP2—chronic kidney failure	0.000188	0.00108	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—EDN1—chronic kidney failure	0.000184	0.00105	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—EDN1—chronic kidney failure	0.000183	0.00105	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—CCL5—chronic kidney failure	0.000182	0.00105	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CCL5—chronic kidney failure	0.000181	0.00104	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PTH—chronic kidney failure	0.000181	0.00104	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PTH—chronic kidney failure	0.000179	0.00103	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—CYP2B6—chronic kidney failure	0.000178	0.00102	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CYBB—chronic kidney failure	0.000176	0.00101	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—AVP—chronic kidney failure	0.000176	0.00101	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—CYP2B6—chronic kidney failure	0.000175	0.00101	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic kidney failure	0.000175	0.001	CbGpPWpGaD
Conivaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic kidney failure	0.000175	0.001	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CYBB—chronic kidney failure	0.000175	0.001	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—AVP—chronic kidney failure	0.000174	0.000999	CbGpPWpGaD
Conivaptan—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic kidney failure	0.000173	0.00099	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—EDN1—chronic kidney failure	0.000167	0.000957	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—FGF23—chronic kidney failure	0.000167	0.000955	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—EDN1—chronic kidney failure	0.000166	0.00095	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CCL5—chronic kidney failure	0.000166	0.00095	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—FGF23—chronic kidney failure	0.000165	0.000948	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CCL5—chronic kidney failure	0.000164	0.000943	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—CCR5—chronic kidney failure	0.000164	0.000942	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CCR5—chronic kidney failure	0.000163	0.000936	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—ALB—chronic kidney failure	0.000159	0.000913	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NPY—chronic kidney failure	0.000157	0.000899	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NPY—chronic kidney failure	0.000156	0.000893	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—CYP2C18—chronic kidney failure	0.000154	0.000884	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—CYP2C18—chronic kidney failure	0.000152	0.000872	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—OXT—chronic kidney failure	0.000151	0.000867	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CRH—chronic kidney failure	0.000151	0.000867	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CRH—chronic kidney failure	0.00015	0.000861	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—OXT—chronic kidney failure	0.00015	0.000861	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CCR5—chronic kidney failure	0.000149	0.000856	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CCR5—chronic kidney failure	0.000148	0.00085	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NCF1—chronic kidney failure	0.000145	0.000831	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NCF1—chronic kidney failure	0.000144	0.000825	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NPS—chronic kidney failure	0.000143	0.000822	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NPS—chronic kidney failure	0.000142	0.000816	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic kidney failure	0.000142	0.000813	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—F2—chronic kidney failure	0.000141	0.000808	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—DRD1—chronic kidney failure	0.000141	0.000806	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—F2—chronic kidney failure	0.00014	0.000803	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—DRD1—chronic kidney failure	0.00014	0.000801	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CYBA—chronic kidney failure	0.000136	0.000781	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CYBA—chronic kidney failure	0.000135	0.000775	CbGpPWpGaD
Conivaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—chronic kidney failure	0.00013	0.000748	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—POMC—chronic kidney failure	0.000128	0.000736	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—F2—chronic kidney failure	0.000128	0.000734	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—CYP2C19—chronic kidney failure	0.000128	0.000733	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—POMC—chronic kidney failure	0.000128	0.000731	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—F2—chronic kidney failure	0.000127	0.000729	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—CYP2C19—chronic kidney failure	0.000126	0.000723	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HBEGF—chronic kidney failure	0.00012	0.000686	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HBEGF—chronic kidney failure	0.000119	0.000681	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—PTGS1—chronic kidney failure	0.000117	0.00067	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—POMC—chronic kidney failure	0.000117	0.000669	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—POMC—chronic kidney failure	0.000116	0.000664	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CCL2—chronic kidney failure	0.000114	0.000654	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CCL2—chronic kidney failure	0.000113	0.00065	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—chronic kidney failure	0.000106	0.000606	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AVP—chronic kidney failure	0.000104	0.000595	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AVP—chronic kidney failure	0.000103	0.00059	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—EDN1—chronic kidney failure	9.86e-05	0.000565	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—EDN1—chronic kidney failure	9.79e-05	0.000561	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCL5—chronic kidney failure	9.79e-05	0.000561	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCL5—chronic kidney failure	9.72e-05	0.000557	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—LPL—chronic kidney failure	9.57e-05	0.000549	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—LPL—chronic kidney failure	9.5e-05	0.000545	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NGF—chronic kidney failure	9.06e-05	0.00052	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NGF—chronic kidney failure	9e-05	0.000516	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCR5—chronic kidney failure	8.82e-05	0.000506	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCR5—chronic kidney failure	8.75e-05	0.000502	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—F2—chronic kidney failure	7.56e-05	0.000434	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—CYP1A1—chronic kidney failure	7.53e-05	0.000432	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—F2—chronic kidney failure	7.51e-05	0.000431	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—CYP1A1—chronic kidney failure	7.43e-05	0.000426	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IRS1—chronic kidney failure	7.16e-05	0.00041	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IRS1—chronic kidney failure	7.1e-05	0.000407	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—POMC—chronic kidney failure	6.89e-05	0.000395	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—POMC—chronic kidney failure	6.84e-05	0.000392	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCL2—chronic kidney failure	6.74e-05	0.000387	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCL2—chronic kidney failure	6.69e-05	0.000384	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IGF1—chronic kidney failure	6.63e-05	0.00038	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IGF1—chronic kidney failure	6.58e-05	0.000377	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SERPINE1—chronic kidney failure	6.29e-05	0.000361	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SERPINE1—chronic kidney failure	6.25e-05	0.000358	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—KRAS—chronic kidney failure	6.23e-05	0.000357	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—KRAS—chronic kidney failure	6.19e-05	0.000355	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NOS3—chronic kidney failure	6.01e-05	0.000345	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NOS3—chronic kidney failure	5.97e-05	0.000342	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—RELA—chronic kidney failure	5.66e-05	0.000324	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—RELA—chronic kidney failure	5.62e-05	0.000322	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—POMC—chronic kidney failure	5.61e-05	0.000322	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—FABP1—chronic kidney failure	5.3e-05	0.000304	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IL6—chronic kidney failure	5.07e-05	0.000291	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IL6—chronic kidney failure	5.03e-05	0.000289	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—AGXT—chronic kidney failure	5.02e-05	0.000288	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GATM—chronic kidney failure	5.02e-05	0.000288	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NFKB1—chronic kidney failure	4.77e-05	0.000274	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NFKB1—chronic kidney failure	4.74e-05	0.000272	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ACAT1—chronic kidney failure	4.59e-05	0.000263	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—VEGFA—chronic kidney failure	4.33e-05	0.000248	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—VEGFA—chronic kidney failure	4.3e-05	0.000246	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—MLXIPL—chronic kidney failure	4.27e-05	0.000245	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TGFB1—chronic kidney failure	3.97e-05	0.000228	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TGFB1—chronic kidney failure	3.94e-05	0.000226	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SLC22A2—chronic kidney failure	3.9e-05	0.000224	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—KRAS—chronic kidney failure	3.68e-05	0.000211	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—KRAS—chronic kidney failure	3.65e-05	0.00021	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ABCG1—chronic kidney failure	3.63e-05	0.000208	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PIP5K1B—chronic kidney failure	3.55e-05	0.000204	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ARG2—chronic kidney failure	3.48e-05	0.0002	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LCAT—chronic kidney failure	3.41e-05	0.000196	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—DDC—chronic kidney failure	3.13e-05	0.00018	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PRKD1—chronic kidney failure	3.04e-05	0.000174	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PRKAG2—chronic kidney failure	3.04e-05	0.000174	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP2B6—chronic kidney failure	3.04e-05	0.000174	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL6—chronic kidney failure	2.99e-05	0.000172	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL6—chronic kidney failure	2.97e-05	0.00017	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SREBF2—chronic kidney failure	2.85e-05	0.000163	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GCKR—chronic kidney failure	2.75e-05	0.000158	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ABCC3—chronic kidney failure	2.75e-05	0.000158	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LPIN1—chronic kidney failure	2.69e-05	0.000154	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LRP2—chronic kidney failure	2.64e-05	0.000151	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP2C18—chronic kidney failure	2.64e-05	0.000151	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CPT1A—chronic kidney failure	2.24e-05	0.000129	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LIPC—chronic kidney failure	2.19e-05	0.000125	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP2C19—chronic kidney failure	2.19e-05	0.000125	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SCARB1—chronic kidney failure	2.02e-05	0.000116	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PTGS1—chronic kidney failure	2e-05	0.000115	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SREBF1—chronic kidney failure	1.96e-05	0.000112	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HMGCR—chronic kidney failure	1.91e-05	0.000109	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—FASN—chronic kidney failure	1.87e-05	0.000107	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ABCA1—chronic kidney failure	1.7e-05	9.74e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CAT—chronic kidney failure	1.44e-05	8.25e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ABCB1—chronic kidney failure	1.4e-05	8.02e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LPL—chronic kidney failure	1.33e-05	7.65e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP1A1—chronic kidney failure	1.29e-05	7.38e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—MTHFR—chronic kidney failure	1.2e-05	6.88e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PPARA—chronic kidney failure	1.18e-05	6.75e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—POMC—chronic kidney failure	9.6e-06	5.51e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALB—chronic kidney failure	8.75e-06	5.02e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NOS3—chronic kidney failure	8.37e-06	4.8e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PTGS2—chronic kidney failure	7.66e-06	4.39e-05	CbGpPWpGaD
